Internal Cutter Memo from Marie Tatt to Eli Greene regarding HTLV-III antibodies in some blood products and the widespread concern of the safety of blood products, and that the processes used to eliminate the virus are generally inadequate. Also discusses Bayer's monitoring of seroconversion of their own users.